17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus.
about
Defining the sister rat mammary tumor cell lines HH-16 cl.2/1 and HH-16.cl.4 as an in vitro cell model for Erbb2NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinomaFLJ25439, a novel cytokinesis-associated protein, induces tetraploidization and maintains chromosomal stability via enhancing expression of endoplasmic reticulum stress chaperonesEvolution of neoplastic cell lineages in Barrett oesophagusGenome management and mismanagement--cell-level opportunities and challenges of whole-genome duplicationEarly events during neoplastic progression in Barrett's esophagusProgressive telomere dysfunction causes cytokinesis failure and leads to the accumulation of polyploid cellsMolecular changes in the progression of Barrett's oesophagusInactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression riskNovel roles for p53 in the genesis and targeting of tetraploid cancer cellsTranscriptome analysis of tetraploid cells identifies cyclin D2 as a facilitator of adaptation to genome doubling in the presence of p53Vascular smooth muscle polyploidization as a biomarker for aging and its impact on differential gene expressionLats2/Kpm is required for embryonic development, proliferation control and genomic integrityThe causes and consequences of genetic heterogeneity in cancer evolutionMolecular biology of Barrett's adenocarcinoma.Persistent telomere damage induces bypass of mitosis and tetraploidy.Cytokinesis failure due to derailed integrin traffic induces aneuploidy and oncogenic transformation in vitro and in vivo.Transcriptional regulation by normal epithelium of premalignant to malignant progression in Barrett's esophagusHer-2/neu gene amplification, elevated mRNA expression, and protein overexpression in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.p16 mutation spectrum in the premalignant condition Barrett's esophagus.Interrelationship between TP53 gene deletion, protein expression and chromosome 17 aneusomy in gastric adenocarcinoma.Integrins promote cytokinesis through the RSK signaling axis.Cyclin D mediates tolerance of genome-doubling in cancers with functional p53.Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagusHigh-throughput screens in diploid cells identify factors that contribute to the acquisition of chromosomal instabilitySingle nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression.Barrett's esophagus: progression to adenocarcinoma and markers.p53 dependent centrosome clustering prevents multipolar mitosis in tetraploid cellsThe SET domain protein, Set3p, promotes the reliable execution of cytokinesis in Schizosaccharomyces pombe.Absolute quantification of somatic DNA alterations in human cancerFormation of bipolar spindles with two centrosomes in tetraploid cells established from normal human fibroblasts.Review article: a conceptual approach to understanding the molecular mechanisms of cancer development in Barrett's oesophagus.Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma.Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosis.Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma.Elucidation of proliferative capability of mononuclear tetraploid cells, emerging spontaneously from diploid cells, using image cytometry and fluorescence in situ hybridization.Quantitative characterization of preneoplastic progression using single-cell computed tomography and three-dimensional karyometrySurveillance in Barrett's oesophagus: a personal viewTolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution.Progressive silencing of p14ARF in oesophageal adenocarcinoma.
P2860
Q21134904-967BB518-2F84-4E9C-A146-113D97C54A04Q21563424-92CA253E-DDCF-40B6-B56E-1D1DE2F1B726Q24321782-4D118B60-57CB-4C96-99E8-A919F8232C35Q24676889-7538D6AB-86C2-44BC-9240-9F5A2D878083Q26774293-EB4AA1FB-3662-49B5-9222-64E791854B1DQ26825349-48BADF94-2DA3-4ED4-BC1C-2FE4DC5EF17DQ27334085-7A2E6818-FB54-4CCF-8DD9-494CFAE23008Q28219148-8D169099-2AFE-4942-A0EB-7065431BC7BEQ28244692-8BB57DDF-3E26-4046-8F31-187AC670411CQ28544803-C937F122-9712-4D64-A737-E986D1C0FB3DQ28552677-187D4C2A-133F-4C2A-9E69-2C13A8575839Q28568654-9CE1226C-CBAD-4E8D-87C0-C0BB44E4F9FEQ28594156-CB0EE668-1588-4C6D-9B17-A601F9ED5BE9Q29615848-50BF1FDF-8D8F-4CB4-881E-90BF2705919EQ30327935-A742B4CF-0BD2-4F3C-B4B5-3FA553D3ADA4Q30494078-B1485665-F844-4716-8A50-A0C7585A198BQ30524194-BC2A6C6B-F91F-4C07-BF00-CE20A87456A7Q30820949-94E8B39B-C34C-4DB0-802A-BBB67D8B8F99Q30992830-7FAEBE5C-4C48-4923-896E-5F5213A0537BQ33388259-FE0D3ACD-2185-4C73-A247-D28159A07FD2Q33484376-B96781DF-79B9-4C91-8B50-1ACAAF51258BQ33557686-A7AD367B-719B-4D42-B83C-716F6204C0F6Q33564829-F9D950F5-4FF6-4B21-A057-55501A8266CBQ33611018-43C56E19-DE4A-46BD-AA84-F40C5D34EBB8Q33659911-BF961154-687F-4BDE-9BBB-0E1D838BD622Q33902184-69C6DFC3-22AF-4022-A62B-98FB9AF79919Q34032319-61921594-3B2C-40D6-9F67-1DFC06C85CA4Q34072697-47E6EC13-274B-4AEC-A494-57B2731E3B22Q34162742-9DDEFA8F-8874-4275-B4EE-5F684739A03AQ34271693-E2335EC1-5959-416B-9CA9-CCF81BACA3F0Q34303715-625DC305-0D80-457C-8F4F-38561BA66F6FQ34319309-F4A84430-3247-48F8-A688-51331C0929EDQ34344115-B5BA1979-1505-41B1-B924-A3822E2C3448Q34385125-D319D411-3D30-4601-B2EA-E459FC4C7E1DQ34586242-321EE907-7BC6-498B-AB83-8A8E74169F75Q34732417-F00D4A4A-ED85-405B-9F8B-4330C8403BE9Q34747959-4CBB4090-0721-4D87-9AE6-B19C952D4C1CQ34769005-E45DB98A-E58E-4C25-88C6-16CE26376B0FQ34946877-20AE4E2A-7EAF-4665-98B1-747C4ED373F7Q34995366-26502828-1F7E-42C2-8F0F-532761D368F4
P2860
17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
17p (p53) allelic losses, 4N ( ...... ploidy in Barrett's esophagus.
@en
17p (p53) allelic losses, 4N ( ...... ploidy in Barrett's esophagus.
@nl
type
label
17p (p53) allelic losses, 4N ( ...... ploidy in Barrett's esophagus.
@en
17p (p53) allelic losses, 4N ( ...... ploidy in Barrett's esophagus.
@nl
prefLabel
17p (p53) allelic losses, 4N ( ...... ploidy in Barrett's esophagus.
@en
17p (p53) allelic losses, 4N ( ...... ploidy in Barrett's esophagus.
@nl
P2093
P2860
P356
P1476
17p (p53) allelic losses, 4N ( ...... ploidy in Barrett's esophagus.
@en
P2093
C A Sanchez
D S Levine
M T Barrett
P C Galipeau
P S Rabinovitch
P2860
P304
P356
10.1073/PNAS.93.14.7081
P407
P577
1996-07-01T00:00:00Z